Staff

ModMed® CEO and Cofounder Daniel Cane Earns Place on The Healthcare Technology Report’s ‘Top 50 Healthcare Technology CEOs of 2022’ List

The award recognizes some of the most accomplished executives in the healthcare technology industry BOCA RATON, Fla.--(BUSINESS WIRE)--ModMed® announced today...

Meet Nanomerics CSO in Montreal This Summer – Nanomerics CSO to Give Plenary Lecture at Controlled Release Society Annual Meeting and Expo in Montreal on 13th July 2022

LONDON, UK / ACCESSWIRE / July 11, 2022 /  Nanomerics Ltd., a private speciality pharmaceutical company, today announced that Nanomerics' Chief...

Moderna’s Omicron-Containing Bivalent Booster Candidate, mRNA-1273.214, Demonstrates Significantly Higher Neutralizing Antibody Response Against Omicron Subvariants BA.4/5 Compared To Currently Authorized Booster

mRNA-1273.214 has now demonstrated significantly higher antibody titers against all tested variants, including Omicron BA.1 and BA.4/5 subvariants, ancestral virus,...

Arcutis Biotherapeutics Announces Health Canada Accepts for Review the New Drug Submission for Roflumilast Cream for Adults and Adolescents with Plaque Psoriasis

Submission supported by positive clinical data from the pivotal Phase 3 DERMIS-1 and DERMIS-2 clinical studies, as well as results...

Aquestive Therapeutics Reports Positive Results from Final Two Arms of EPIPHAST Trial Supporting Performance and Real-World Functionality of AQST-109 Epinephrine Oral Film

Study results for the sublingual administration of AQST-109 epinephrine oral film after consuming a peanut butter sandwich demonstrates consistent Tmax...

error: Content is protected !!